Stephens & Co. Maintains Equal-Weight on Alignment Healthcare, Raises Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel maintains an Equal-Weight rating on Alignment Healthcare (NASDAQ:ALHC) and raises the price target from $6 to $7.
May 03, 2024 | 6:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stephens & Co. maintains an Equal-Weight rating on Alignment Healthcare, raising the price target from $6 to $7.
The increase in price target by Stephens & Co. reflects a positive outlook on Alignment Healthcare's stock, suggesting potential upside. This could lead to increased investor interest and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100